134 related articles for article (PubMed ID: 30001262)
1. Subjective Versus Objective Measures of Medication Adherence in Adolescents/Young Adults with Attention-Deficit Hyperactivity Disorder.
Schaefer MR; Wagoner ST; Young ME; Rawlinson AR; Kavookjian J; Shapiro SK; Gray WN
J Dev Behav Pediatr; 2019 Jan; 40(1):54-59. PubMed ID: 30001262
[TBL] [Abstract][Full Text] [Related]
2. Review of medication adherence in children and adults with ADHD.
Adler LD; Nierenberg AA
Postgrad Med; 2010 Jan; 122(1):184-91. PubMed ID: 20107302
[TBL] [Abstract][Full Text] [Related]
3. Adherence to Attention-Deficit/Hyperactivity Disorder Medication During the Transition to College.
Schaefer MR; Rawlinson AR; Wagoner ST; Shapiro SK; Kavookjian J; Gray WN
J Adolesc Health; 2017 Jun; 60(6):706-713. PubMed ID: 28162841
[TBL] [Abstract][Full Text] [Related]
4. Transition to College and Adherence to Prescribed Attention Deficit Hyperactivity Disorder Medication.
Gray WN; Kavookjian J; Shapiro SK; Wagoner ST; Schaefer MR; Resmini Rawlinson A; Hinnant JB
J Dev Behav Pediatr; 2018 Jan; 39(1):1-9. PubMed ID: 28991147
[TBL] [Abstract][Full Text] [Related]
5. Does a multimethod approach improve identification of medication nonadherence in adolescents with chronic kidney disease?
Pruette CS; Coburn SS; Eaton CK; Brady TM; Tuchman S; Mendley S; Fivush BA; Eakin MN; Riekert KA
Pediatr Nephrol; 2019 Jan; 34(1):97-105. PubMed ID: 30116892
[TBL] [Abstract][Full Text] [Related]
6. Medication adherence and symptom reduction in adults treated with mixed amphetamine salts in a randomized crossover study.
Adler LA; Lynch LR; Shaw DM; Wallace SP; Ciranni MA; Briggie AM; Kulaga A; O'Donnell KE; Faraone SV
Postgrad Med; 2011 Sep; 123(5):71-9. PubMed ID: 21904088
[TBL] [Abstract][Full Text] [Related]
7. Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant behavioral treatment.
Pappadopulos E; Jensen PS; Chait AR; Arnold LE; Swanson JM; Greenhill LL; Hechtman L; Chuang S; Wells KC; Pelham W; Cooper T; Elliott G; Newcorn JH
J Am Acad Child Adolesc Psychiatry; 2009 May; 48(5):501-510. PubMed ID: 19307987
[TBL] [Abstract][Full Text] [Related]
8. Reported Side or Adverse Effects Associated with Medication Nonadherence Among Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
Barnard-Brak L; Kudesey C
J Child Adolesc Psychopharmacol; 2022 Dec; 32(10):539-542. PubMed ID: 36548362
[No Abstract] [Full Text] [Related]
9. Persistence and Adherence to Psychostimulants, and Psychological Well-Being Up to 3 Years After Specialized Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Naturalistic Follow-Up Study.
Bijlenga D; Kulcu S; van Gellecum T; Eryigit Z; Kooij JJS
J Clin Psychopharmacol; 2017 Dec; 37(6):689-696. PubMed ID: 29049077
[TBL] [Abstract][Full Text] [Related]
10. Barriers to Treatment Adherence Among College Students with Attention-Deficit/Hyperactivity Disorder.
Wagoner ST; Schaefer MR; Rawlinson AR; Shapiro SK; Kavookjian J; Gray WN
J Dev Behav Pediatr; 2020 Jan; 41(1):9-15. PubMed ID: 31449195
[TBL] [Abstract][Full Text] [Related]
11. Short- and Long-Term Outcomes of Suboptimal Medication Adherence in Adolescents with Attention-Deficit/Hyperactivity Disorder: A Systematic Literature Review.
Abdallah S; Church E; Levin JB; Chela A; McVoy M
J Child Adolesc Psychopharmacol; 2024 May; 34(4):183-193. PubMed ID: 38700276
[No Abstract] [Full Text] [Related]
12. Multimethod Assessment of Medication Nonadherence and Barriers in Adolescents and Young Adults With Solid Organ Transplants.
Eaton CK; Gutierrez-Colina AM; Quast LF; Liverman R; Lee JL; Mee LL; Reed-Knight B; Cushman G; Chiang G; Romero R; Mao C; Garro R; Blount RL
J Pediatr Psychol; 2018 Aug; 43(7):789-799. PubMed ID: 29562247
[TBL] [Abstract][Full Text] [Related]
13. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease.
Hommel KA; Davis CM; Baldassano RN
Inflamm Bowel Dis; 2009 Apr; 15(4):589-93. PubMed ID: 18985746
[TBL] [Abstract][Full Text] [Related]
14. Medication Non-Adherence and Tolerance Breaks Among Adolescents and Young Adults With ADHD.
Barnard-Brak L; Marques A; Kudesey C
J Atten Disord; 2023 Jul; 27(9):1020-1026. PubMed ID: 37039124
[TBL] [Abstract][Full Text] [Related]
15. Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder.
Emilsson M; Gustafsson PA; Öhnström G; Marteinsdottir I
Eur Child Adolesc Psychiatry; 2017 May; 26(5):559-571. PubMed ID: 27848023
[TBL] [Abstract][Full Text] [Related]
16. Objective QbTest and subjective evaluation of stimulant treatment in adult attention deficit-hyperactivity disorder.
Bijlenga D; Jasperse M; Gehlhaar SK; Sandra Kooij JJ
Eur Psychiatry; 2015 Jan; 30(1):179-85. PubMed ID: 25172155
[TBL] [Abstract][Full Text] [Related]
17. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis.
Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu EQ; Erder MH
J Med Econ; 2013 Jul; 16(7):962-75. PubMed ID: 23621503
[TBL] [Abstract][Full Text] [Related]
18. Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.
Ayaz M; Ayaz AB; Soylu N; Yüksel S
J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):442-7. PubMed ID: 25010598
[TBL] [Abstract][Full Text] [Related]
19. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
Ibrahim el SR
Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
[TBL] [Abstract][Full Text] [Related]
20. Osmotic Release Oral System Methylphenidate Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Chinese Youth: 8-Week Comparative Efficacy and 1-Year Follow-Up.
Su Y; Yang L; Stein MA; Cao Q; Wang Y
J Child Adolesc Psychopharmacol; 2016 May; 26(4):362-71. PubMed ID: 26779845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
